217 related articles for article (PubMed ID: 11485173)
41. Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-beta-cyclodextrin.
Vlachou M; Papaïoannou G
J Biomater Appl; 2003 Jan; 17(3):197-206. PubMed ID: 12614084
[TBL] [Abstract][Full Text] [Related]
42. Direct compression tablets containing a series of four beta-cyclodextrin complexes formed by neutralizing an acidic drug.
Moore E; Bergamo R; Casella R
Drug Dev Ind Pharm; 2000 Dec; 26(12):1259-70. PubMed ID: 11147126
[TBL] [Abstract][Full Text] [Related]
43. Characterization of the Supermolecular Structure of Polydatin/6-O-α-Maltosyl-β-cyclodextrin Inclusion Complex.
Liu B; Li Y; Xiao H; Liu Y; Mo H; Ma H; Liang G
J Food Sci; 2015 Jun; 80(6):C1156-61. PubMed ID: 25916244
[TBL] [Abstract][Full Text] [Related]
44. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
Miyake K; Hirayama F; Uekama K
J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
[TBL] [Abstract][Full Text] [Related]
45. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
46. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
47. Niosomes encapsulating Ibuprofen-cyclodextrin complexes: preparation and characterization.
Marianecci C; Rinaldi F; Esposito S; Di Marzio L; Carafa M
Curr Drug Targets; 2013 Aug; 14(9):1070-8. PubMed ID: 23531114
[TBL] [Abstract][Full Text] [Related]
48. Formation of host-guest complexes of β-cyclodextrin and perfluorooctanoic acid.
Karoyo AH; Borisov AS; Wilson LD; Hazendonk P
J Phys Chem B; 2011 Aug; 115(31):9511-27. PubMed ID: 21688796
[TBL] [Abstract][Full Text] [Related]
49. Characterization of aqueous and solid inclusion complexes of diuron and isoproturon with beta-cyclodextrin.
Dupuy N; Marquis S; Vanhove G; Bria M; Kister J; Vrielynck L
Appl Spectrosc; 2004 Jun; 58(6):711-8. PubMed ID: 15198824
[TBL] [Abstract][Full Text] [Related]
50. Membrane penetration enhancement of ibuprofen using supersaturation.
Iervolino M; Raghavan SL; Hadgraft J
Int J Pharm; 2000 Apr; 198(2):229-38. PubMed ID: 10767571
[TBL] [Abstract][Full Text] [Related]
51. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
52. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
Rawat S; Jain SK
Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
[TBL] [Abstract][Full Text] [Related]
53. Inclusion complexation of nimesulide with beta-cyclodextrins.
Vavia PR; Adhage NA
Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611
[TBL] [Abstract][Full Text] [Related]
54. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
55. Inclusion complexation of propofol with 2-hydroxypropyl-beta-cyclodextrin. Physicochemical, nuclear magnetic resonance spectroscopic studies, and anesthetic properties in rat. trapani@ippo.uniba.it.
Trapani G; Latrofa A; Franco M; Lopedota A; Sanna E; Liso G
J Pharm Sci; 1998 Apr; 87(4):514-8. PubMed ID: 9548907
[TBL] [Abstract][Full Text] [Related]
56. Inclusion complexes of phosphorylated daidzein derivatives with β-cyclodextrin: Preparation and inclusion behavior study.
Xiao Y; Yang L; Mao P; Yuan J; Deng Y; Qu L
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Jan; 85(1):298-302. PubMed ID: 22041503
[TBL] [Abstract][Full Text] [Related]
57. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.
Bayomi MA; Abanumay KA; Al-Angary AA
Int J Pharm; 2002 Aug; 243(1-2):107-17. PubMed ID: 12176299
[TBL] [Abstract][Full Text] [Related]
58. Host-guest inclusion complex of propafenone hydrochloride with α- and β-cyclodextrins: spectral and molecular modeling studies.
Siva S; Thulasidhasan J; Rajendiran N
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():559-67. PubMed ID: 23872014
[TBL] [Abstract][Full Text] [Related]
59. Formulation studies on ibuprofen sodium-cationic dextran conjugate: effect on tableting and dissolution characteristics of ibuprofen.
Abioye AO; Kola-Mustapha A
Drug Dev Ind Pharm; 2016 Jan; 42(1):39-59. PubMed ID: 25826253
[TBL] [Abstract][Full Text] [Related]
60. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
